A RANDOMIZED, PARTIAL-BLINDED, MULTI-CENTER, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF A HUMAN PLASMA-DERIVED ALPHA PROTEINASE INHIBITOR IN CHILDREN AND ADULTS WITH RECENT ONSET TYPE 1 DIABETES MELLITUS
Principal Investigator(s)
Hale,Daniel E
Funded by
GRIFOLS
Research Start Date
Status
Inactive